Park EH, Koh SS, Srisuttee R, Cho IR, Min HJ, Jhun BH, Lee YS, Jang KL, Kim CH, Johnston RN, et al.: Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cells. Cancer Gene Ther 2009, 16 (5) : 453–461.PubMedCrossRef 6. Mukherji A, Janbandhu VC, Kumar V: HBx protein selleck chemical modulates PI3K/Akt pathway to overcome genotoxic stress-induced destabilization of cyclin D1 and arrest of cell cycle. Indian J Biochem Biophys 2009, 46 (1) : 37–44.PubMed 7. He Y, Sun HQ, He XE, Wang WL, Lei JH: Knockdown of HBx by RNAi inhibits proliferation and enhances chemotherapy-induced apoptosis in hepatocellular carcinoma cells. Med Oncol

2009. 8. Cheng P, Li Y, Yang L, Wen Y, Shi W, Mao Y, Chen P, Lv H, Tang Q, Wei Y: Hepatitis B virus X protein (HBx) induces G2/M arrest and apoptosis through sustained activation of cyclin B1-CDK1 kinase. Oncol Rep 2009, 22 (5) : 1101–1107.PubMed 9. Cheng B, Guo X, Zheng Y, Wang Y, Liu C, Li P: The effects of HBx gene on the expression of DNA repair enzymes hOGG1 and hMYHalpha mRNA in HepG2 cells. J Huazhong

Univ Sci Technolog Med Sci 2009, 29 (2) : 187–192.PubMedCrossRef 10. Kuo CY, Wang JC, Wu CC, Hsu SL, Hwang GY: Effects of hepatitis B virus X protein (HBx) on cell-growth inhibition in a CCL13-HBx stable cell line. Intervirology 2008, 51 (1) : 26–32.PubMedCrossRef 11. Butel JS, Lee TH, Slagle BL: Is the DNA repair system involved in hepatitis-B-virus-mediated hepatocellular carcinogenesis? Trends Microbiol 1996, 4 (3) : 119–124.PubMedCrossRef isometheptene 12. Nassal HDAC inhibitor M, Schaller H: Hepatitis B virus replication. Trends Microbiol 1993, 1 (6) : 221–228.PubMedCrossRef 13. Han M, Yan W,

Guo W, Xi D, Zhou Y, Li W, Gao S, Liu M, Levy G, Luo X, et al.: Hepatitis B virus-induced hFGL2 transcription is dependent on c-Ets-2 and MAPK signal pathway. J Biol Chem 2008, 283 (47) : 32715–32729.PubMedCrossRef 14. Kang-Park S, Lee JH, Shin JH, Lee YI: Activation of the IGF-II gene by HBV-X protein requires PKC and p44/p42 map kinase Akt cancer signalings. Biochem Biophys Res Commun 2001, 283 (2) : 303–307.PubMedCrossRef 15. Choi CY, Choi BH, Park GT, Rho HM: Activating transcription factor 2 (ATF2) down-regulates hepatitis B virus X promoter activity by the competition for the activating protein 1 binding site and the formation of the ATF2-Jun heterodimer. J Biol Chem 1997, 272 (27) : 16934–16939.PubMedCrossRef 16. Li B, Gao B, Ye L, Han X, Wang W, Kong L, Fang X, Zeng Y, Zheng H, Li S, et al.: Hepatitis B virus X protein (HBx) activates ATF6 and IRE1-XBP1 pathways of unfolded protein response. Virus Res 2007, 124 (1–2) : 44–49.PubMedCrossRef 17. Maguire HF, Hoeffler JP, Siddiqui A: HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 1991, 252 (5007) : 842–844.PubMedCrossRef 18. Cheong JH, Yi M, Lin Y, Murakami S: Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation.